Literature DB >> 19654407

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.

Simrit Parmar1, Marcos Del Lima, Yizhou Zou, Poliana A Patah, Ping Liu, Pedro Cano, Gabriela Rondon, Susana Pesoa, Leandro de Padua Silva, Muzaffar H Qazilbash, Chitra Hosing, Uday Popat, Partow Kebriaei, Elizabeth J Shpall, Sergio Giralt, Richard E Champlin, Peter Stastny, Marcelo Fernandez-Vina.   

Abstract

The polymorphic products of major histocompatibility complex class I-related chain A (MICA) genes are important in solid organ transplantation rejection. MICA expression is limited to gut epithelium and may play a role in triggering acute graft-versus-host disease (aGVHD). A total of 236 recipients of unrelated donor transplantation were studied. Donor-recipient human leukocyte antigen (HLA) match was 10/10 human leukocyte antigen (HLA-A, -B, -C, -DRB1, -DQB1) in 73% and MICA mismatch in 8.4%. Because of physical vicinity of the loci, MICA mismatch was significantly associated with mismatch at HLA-B and HLA-C. A higher rate of grade II-IV aGVHD was seen in MICA-mismatched patients (80% vs 40%, P = .003) irrespective of degree of HLA matching (HLA 10/10 match: 75% vs 39%, P = .02) and HLA any mismatch (83% vs 46%, P = .003). The rate of grade II-IV gastrointestinal aGVHD was also higher in MICA-mismatched patients (35% vs 17%, P = .05). We conclude that MICA may represent novel a transplantation antigen recognized by human allogeneic T cells. This study was registered at ClinicalTrials.gov (Identifier NCT00506922).

Entities:  

Mesh:

Year:  2009        PMID: 19654407      PMCID: PMC4784289          DOI: 10.1182/blood-2009-05-223172

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Population study of allelic diversity in the human MHC class I-related MIC-A gene.

Authors:  E W Petersdorf; K B Shuler; G M Longton; T Spies; J A Hansen
Journal:  Immunogenetics       Date:  1999-07       Impact factor: 2.846

2.  Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA.

Authors:  Vannary Tieng; Chantal Le Bouguénec; Laurence du Merle; Philippe Bertheau; Pierre Desreumaux; Anne Janin; Dominique Charron; Antoine Toubert
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

3.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

4.  Frequency of MIC antibody in rejected renal transplant patients without HLA antibody.

Authors:  Kazuo Mizutani; Paul I Terasaki; Remi N J Shih; Rui Pei; Miyuki Ozawa; Jarhow Lee
Journal:  Hum Immunol       Date:  2006-03-31       Impact factor: 2.850

5.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Authors:  Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis Confer; Marcelo Fernandez-Vina; Alexandra Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann Begovich; William Hildebrand; Effie Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond Yunis; Daniel Weisdorf
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

6.  Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease.

Authors:  Monique Gannagé; Agnès Buzyn; Sofia I Bogiatzi; Marion Lambert; Vassili Soumelis; Liliane Dal Cortivo; Marina Cavazzana-Calvo; Nicole Brousse; Sophie Caillat-Zucman
Journal:  Transplantation       Date:  2008-03-27       Impact factor: 4.939

7.  A second lineage of mammalian major histocompatibility complex class I genes.

Authors:  S Bahram; M Bresnahan; D E Geraghty; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

Review 8.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

9.  Mapping MHC-resident transplantation determinants.

Authors:  Mari Malkki; Ted A Gooley; Mary M Horowitz; Lena Absi; Frank T Christiansen; Jan J Cornelissen; Anne Dormoy; Valerie Dubois; Katia Gagne; Eliane Gluckman; Michael D Haagenson; Machteld Oudshoorn; Stephen Spellman; Effie W Petersdorf
Journal:  Biol Blood Marrow Transplant       Date:  2007-08       Impact factor: 5.742

10.  Allelic diversity of MICA gene and MICA/HLA-B haplotypic variation in a population of the Murcia region in southeastern Spain.

Authors:  Daniel Lucas; José Antonio Campillo; Ruth López-Hernández; Pedro Martínez-García; Manuela López-Sánchez; Carmen Botella; Gema Salgado; Alfredo Minguela; María Rocío Alvarez-López; Manuel Muro
Journal:  Hum Immunol       Date:  2008-08-15       Impact factor: 2.850

View more
  30 in total

1.  Unrelated donor transplantation for acute myelogenous leukemia in first remission.

Authors:  Qaiser Bashir; Borje S Andersson; Marcelo Fernandez-Vina; Leandro de Padua Silva; Sergio Giralt; Alexandre Chiattone; Wei Wei; Manish Sharma; Paolo Anderlini; Elizabeth J Shpall; Uday Popat; Morgani Rodrigues; Richard E Champlin; Marcos de Lima
Journal:  Biol Blood Marrow Transplant       Date:  2010-11-16       Impact factor: 5.742

2.  Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study.

Authors:  Medhat Askar; David Sayer; Tao Wang; Michael Haagenson; Stephen R Spellman; Stephanie J Lee; Abeer Madbouly; Katharina Fleischhauer; Katharine C Hsu; Michael R Verneris; Dawn Thomas; Aiwen Zhang; Ronald M Sobecks; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-08       Impact factor: 5.742

3.  Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

Authors:  Marcos de Lima; Sergio Giralt; Peter F Thall; Leandro de Padua Silva; Roy B Jones; Krishna Komanduri; Thomas M Braun; Hoang Q Nguyen; Richard Champlin; Guillermo Garcia-Manero
Journal:  Cancer       Date:  2010-07-29       Impact factor: 6.860

4.  Transfer of multiple loci of donor's genes to induce recipient tolerance in organ transplantation.

Authors:  Tong Li; Wenqian Zhang; Qing Xu; Shentao Li; Xuehong Tong; Jie Ding; Hui Li; Shengcai Hou; Zhidong Xu; David M Jablons; Liang You
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

Review 5.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

6.  MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.

Authors:  Medhat Askar; Ronald Sobecks; Tao Wang; Mike Haagenson; Navneet Majhail; Abeer Madbouly; Dawn Thomas; Aiwen Zhang; Katharina Fleischhauer; Katharine Hsu; Michael Verneris; Stephanie J Lee; Stephen R Spellman; Marcelo Fernández-Viña
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-14       Impact factor: 5.742

7.  Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.

Authors:  Raphael Carapito; Ismail Aouadi; Angélique Pichot; Perrine Spinnhirny; Aurore Morlon; Irina Kotova; Cécile Macquin; Véronique Rolli; Anne Cesbron; Katia Gagne; Machteld Oudshoorn; Bronno van der Holt; Myriam Labalette; Eric Spierings; Christophe Picard; Pascale Loiseau; Ryad Tamouza; Antoine Toubert; Anne Parissiadis; Valérie Dubois; Catherine Paillard; Myriam Maumy-Bertrand; Frédéric Bertrand; Peter A von dem Borne; Jürgen H E Kuball; Mauricette Michallet; Bruno Lioure; Régis Peffault de Latour; Didier Blaise; Jan J Cornelissen; Ibrahim Yakoub-Agha; Frans Claas; Philippe Moreau; Dominique Charron; Mohamad Mohty; Yasuo Morishima; Gérard Socié; Seiamak Bahram
Journal:  Bone Marrow Transplant       Date:  2020-04-14       Impact factor: 5.483

8.  Identification of the MICA*070 allele by sequencing and phasing.

Authors:  D Moran; S Morishima; M Malkki; E W Petersdorf
Journal:  Hum Immunol       Date:  2012-11-29       Impact factor: 2.850

Review 9.  The major histocompatibility complex: a model for understanding graft-versus-host disease.

Authors:  Effie W Petersdorf
Journal:  Blood       Date:  2013-07-22       Impact factor: 22.113

10.  A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.

Authors:  Qaiser Bashir; Hassan Khan; Peter F Thall; Ping Liu; Nina Shah; Partow Kebriaei; Simrit Parmar; Betul Oran; Stefan Ciurea; Yago Nieto; Roy Jones; Chitra M Hosing; Uday R Popat; Yvonne T Dinh; Gabriela Rondon; Robert Z Orlowski; Jatin J Shah; Marcos De Lima; Elizabeth Shpall; Richard Champlin; Sergio Giralt; Muzaffar H Qazilbash
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-17       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.